Literature DB >> 19768530

Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients.

Cheng-Hsuan Wu1, Yu-Ching Chen, Hsin-Hung Wu, Jyuer-Ger Yang, Yu-Jun Chang, Horng-Der Tsai.   

Abstract

PURPOSE: This prospective study was designed to investigate whether anti-Müllerian hormone (AMH) levels at basal and ovulation triggering day are associated with ovarian response and pregnancy outcome for in vitro fertilization (IVF).
METHOD: 60 infertility women undergoing IVF were prospectively studied. On day 3 of the menstrual cycle (D3), measurements of AMH, inhibin B, FSH, LH, and E2 and ultrasound evaluation of antral follicle count (AFC) were performed. Serum AMH and inhibin B levels were remeasured on the day of hCG administration (DhCG). The outcome measures were the number of retrieved oocytes and clinical pregnancy.
RESULTS: Number of retrieved oocytes was statistically significant and correlated with D3 AMH, AFC, DhCG AMH, DhCG inhibin B, FSH, and age (r=0.885, 0.874, 0.742, 0.732, -0.521, -0.385, respectively). Statistically significant differences were found between pregnant and non-pregnant women regarding D3 AMH and AFC. Multiple regression analysis for prediction of pregnancy showed D3 AMH to be a good predictor of clinical pregnancy.
CONCLUSION: AMH correlates better than age, FSH, and inhibin B with the number of retrieved oocytes. Serum basal AMH may offer a better prognostic value for clinical pregnancy than other currently available markers of IVF outcome in our preliminary study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19768530      PMCID: PMC2758947          DOI: 10.1007/s10815-009-9332-8

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  60 in total

1.  Dynamic assays of inhibin B and oestradiol following buserelin acetate administration as predictors of ovarian response in IVF.

Authors:  A Ravhon; S Lavery; S Michael; M Donaldson; R Margara; G Trew; R Winston
Journal:  Hum Reprod       Date:  2000-11       Impact factor: 6.918

2.  Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve.

Authors:  I A J van Rooij; F J M Broekmans; E R te Velde; B C J M Fauser; L F J M M Bancsi; F H de Jong; A P N Themmen
Journal:  Hum Reprod       Date:  2002-12       Impact factor: 6.918

3.  Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3.

Authors:  Renato Fanchin; Luca Maria Schonäuer; Claudia Righini; Jean Guibourdenche; René Frydman; Joëlle Taieb
Journal:  Hum Reprod       Date:  2003-02       Impact factor: 6.918

Review 4.  Regulation of ovarian function: the role of anti-Müllerian hormone.

Authors:  Alexandra L L Durlinger; Jenny A Visser; Axel P N Themmen
Journal:  Reproduction       Date:  2002-11       Impact factor: 3.906

5.  Antimüllerian hormone serum levels: a putative marker for ovarian aging.

Authors:  Annemarie de Vet; Joop S E Laven; Frank H de Jong; Axel P N Themmen; Bart C J M Fauser
Journal:  Fertil Steril       Date:  2002-02       Impact factor: 7.329

6.  Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles.

Authors:  David B Seifer; David T MacLaughlin; Benjamin P Christian; Bo Feng; Robert M Shelden
Journal:  Fertil Steril       Date:  2002-03       Impact factor: 7.329

7.  A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation.

Authors:  Kannamannadiar Jayaprakasan; Bruce Campbell; James Hopkisson; Ian Johnson; Nick Raine-Fenning
Journal:  Fertil Steril       Date:  2008-11-30       Impact factor: 7.329

8.  Ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography.

Authors:  W Hamish Wallace; Thomas W Kelsey
Journal:  Hum Reprod       Date:  2004-06-17       Impact factor: 6.918

9.  Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.

Authors:  Joop S E Laven; Annemarie G M G J Mulders; Jenny A Visser; Axel P Themmen; Frank H De Jong; Bart C J M Fauser
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

10.  Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

Authors:  Christien Weenen; Joop S E Laven; Anne R M Von Bergh; Mark Cranfield; Nigel P Groome; Jenny A Visser; Piet Kramer; Bart C J M Fauser; Axel P N Themmen
Journal:  Mol Hum Reprod       Date:  2004-02       Impact factor: 4.025

View more
  22 in total

1.  The role of serum AMH and FF AMH in predicting pregnancy outcome in the fresh cycle of IVF/ICSI: a meta-analysis.

Authors:  Lingnv Yao; Wei Zhang; Hong Li; Wenqin Lin
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  The cost of a euploid embryo identified from preimplantation genetic testing for aneuploidy (PGT-A): a counseling tool.

Authors:  Randi H Goldman; Catherine Racowsky; Leslie V Farland; Janis H Fox; Santiago Munné; Lia Ribustello; Elizabeth S Ginsburg
Journal:  J Assist Reprod Genet       Date:  2018-07-31       Impact factor: 3.412

3.  Reduced neurotrophin receptor tropomyosin-related kinase A expression in human granulosa cells: a novel marker of diminishing ovarian reserve.

Authors:  Erkan Buyuk; Nanette Santoro; Hillel W Cohen; Maureen J Charron; Sangita Jindal
Journal:  Fertil Steril       Date:  2011-06-08       Impact factor: 7.329

4.  Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age.

Authors:  Anne Z Steiner; David Pritchard; Frank Z Stanczyk; James S Kesner; Juliana W Meadows; Amy H Herring; Donna D Baird
Journal:  JAMA       Date:  2017-10-10       Impact factor: 56.272

5.  Defining ovarian reserve to better understand ovarian aging.

Authors:  Norbert Gleicher; Andrea Weghofer; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2011-02-07       Impact factor: 5.211

6.  Single nucleotide polymorphisms in the Anti-Müllerian hormone (AMH Ile(49)Ser) and Anti-Müllerian hormone type II receptor (AMHRII -482 A>G) as genetic markers in assisted reproduction technology.

Authors:  Iro Karagiorga; George A Partsinevelos; Despina Mavrogianni; Elli Anagnostou; Ioannis Zervomanolakis; Konstantinos Kallianidis; Petros Drakakis; Dimitris Loutradis
Journal:  J Assist Reprod Genet       Date:  2014-12-27       Impact factor: 3.412

7.  Serum anti-müllerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in IVF/ICSI cycles.

Authors:  Sezai Sahmay; Gökhan Demirayak; Onur Guralp; Pelin Ocal; Levent M Senturk; Engin Oral; Tulay Irez
Journal:  J Assist Reprod Genet       Date:  2012-04-11       Impact factor: 3.412

8.  The significance of antral follicle size prior to stimulation in predicting ovarian response in a multiple dose GnRH antagonist protocol.

Authors:  Qiaohong Lai; Cai Chen; Zhijun Zhang; Shu Zhang; Qilin Yu; Ping Yang; Jun Hu; Cong-Yi Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15

9.  Serum and follicular fluid Anti-Mullerian hormone concentrations at the time of follicle puncture and reproductive outcome.

Authors:  Selma İnat Capkın; Sebnem Ozyer; Rana Karayalçın; Ozlem Moraloğlu; Sarp Ozcan; Mustafa Uğur
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-03-01

10.  Preconception leukocyte telomere length and pregnancy outcomes among women with demonstrated fecundity.

Authors:  Alexandra C Purdue-Smithe; Keewan Kim; Victoria C Andriessen; Anna Z Pollack; Lindsey A Sjaarda; Robert M Silver; Enrique F Schisterman; Sunni L Mumford
Journal:  Hum Reprod       Date:  2021-11-18       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.